PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Phenotype | C0011860|type 2 diabetes mellitus |
| Sentences | 17 |
| PubMedID- 25539716 | Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus. |
| PubMedID- 26385228 | Methods: this randomized, double-blind, placebo-controlled trial was performed among 60 overweight or obese and type 2 diabetes mellitus patients with coronary heart disease aged 40-85 years old. |
| PubMedID- 24083205 | Hence, an open label, prospective, randomized, parallel study was undertaken to investigate the hypothesis that combination therapy with atorvastatin and fenofibrate will be more effective than monotherapy with a statin/fibrate to prevent coronary heart disease in patients with type 2 diabetes mellitus. |
| PubMedID- 23496967 | Background: the aim of the present prospective study was to examine whether lipoprotein (a) [lp(a)] phenotypes and/or low relative lymphocyte concentration (lrlc) are independently associated with coronary heart disease (chd) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22442750 | Aim: to analyze the risk of coronary heart disease in patients with type 2 diabetes mellitus (t2dm) receiving standard medical treatment. |
| PubMedID- 24809916 | Thyroid stimulating hormone levels and risk of coronary heart disease in patients with type 2 diabetes mellitus. |
| PubMedID- 23815539 | Hypertension is a major risk factor in addition to atherosclerosis and type 2 diabetes mellitus for the development of coronary heart disease and strokes. |
| PubMedID- 24142614 | Background: diabetes mellitus is a chronic metabolic disorder that results from various genetic and environmental factors, and type 2 diabetes mellitus (t2dm) combined with coronary heart disease (chd) is one of the most common chronic complications in diabetes. |
| PubMedID- 22629043 | A 58 year old male, a known case of ischaemic heart disease with type 2 diabetes mellitus and hypertension, who had been admitted for cerebellar stroke 2 months back, came with complaints of dry cough- (more at night), gradually increasing breathlessness (new york heart association, nyha grade-i to start with and displaying gradual progression to nyha grade iv in a period of 3 days), and swelling all over the body with minimal abdominal distension. |
| PubMedID- 22039842 | Association between apolipoprotein e-polymorphism and ischemic heart disease patients with or without type 2 diabetes mellitus: a preliminary study in kuwait. |
| PubMedID- 20040882 | Purpose: the cardiovascular disease risk profile and exercise capacity of coronary heart disease patients with type 2 diabetes mellitus (dm) were measured and compared with those of nondiabetic (ndm) patients before and after a 6-week multidisciplinary cardiac rehabilitation program. |
| PubMedID- 26190179 | Plasma brain natriuretic peptide, endothelin-1, and matrix metalloproteinase 9 expression and significance in type 2 diabetes mellitus patients with ischemic heart disease. |
| PubMedID- 20922871 | [hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus]. |
| PubMedID- 23220502 | Methods: a total of 132 type 2 diabetes mellitus without coronary heart disease (t2dm) cases and 135 type 2 diabetes mellitus with coronary heart disease (t2dm+chd) cases received intensive glycemic control. |
| PubMedID- 23155698 | Association analysis between endothelial function related factors and coronary artery stenosis degree in coronary heart disease patients with type 2 diabetes mellitus. |
| PubMedID- 21499988 | It is estimated that in the next 10 years, the majority of all heart disease will be associated with type 2 diabetes mellitus [63]. |
| PubMedID- 25454625 | Objective: to analyze the level of creatine kinase isoenzyme (ckmb), myoglobin, to explore the influence of different glucose-lowering rate on cardiac enzyme in type 2 diabetes mellitus patients with coronary heart disease (t2dmc), to search for the rational glucose-lowering rate. |
Page: 1